Inpharma Weekly

, Volume 1529, Issue 1, pp 8–8 | Cite as

Gemcitabine increases efficacy of standard chemo for NSCLC

Clinical study


Lung Cancer Survival Time Median Survival Gemcitabine Partial Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2006

Personalised recommendations